The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re Morocco and Greenfield Energy Projects

2 Feb 2021 07:00

RNS Number : 6824N
Quadrise Fuels International PLC
02 February 2021
 

2 February 2021

 

Quadrise Fuels International plc

("Quadrise", "QFI", the "Company" and together with its subsidiaries the "Group")

 

Update re Morocco and Greenfield Energy Projects

 

Quadrise is pleased, further to the Company's announcements of 27 November and 18 December 2020, to provide an update on certain of the Company's active programmes.

 

Morocco. Following the completion of the Pilot Trial at one of the client's industrial facilities in Morocco, work continues on the phase 2 study and planning and preparations for the larger industrial-scale trial at another of the client's facilities in Morocco, with engineering and planning meetings taking place as required remotely. The purpose of the industrial trial is to de-risk commercial roll-out and fast-track the phase 2 commercial trial, which is similar in scale and will utilise the same Quadrise MSAR® trial equipment.

 

The Pumping and Heating Unit, which has been designed for both the industrial-scale trial and the phase 2 trial, has now been fabricated and tested at the Quadrise Research Facility ("QRF") and is ready for shipment to Morocco.

 

The industrial trial requires c.60t of MSAR® fuel and the updated COVID-19 restrictions that came into place during December 2020 in the UK and much of Europe have impacted the availability of our preferred third-party MSAR® supply options. However, our contingency plans have enabled us to source an alternative site for MSAR® fuel manufacture, which we are progressing to minimise the impact on the overall programme, with the phase 2 study and the industrial-scale trial now scheduled to be completed as early as possible in H1 2021, subject to Quadrise being able to gain safe access to the test sites in Morocco. QFI will be paid £100,000 for the industrial trial and phase 2 study under existing agreements with the client.

 

Pending a positive outcome of the industrial-scale trial, a new agreement will be finalised for the phase 2 trial that is being planned to follow the industrial trial and is anticipated to commence in Q2 2021. The phase 2 commercial trial is expected to be the final precursor to commercial roll-out.

 

Greenfield Energy, Utah. Quadrise is still awaiting the receipt of oil samples at QRF from Greenfield Energy LLC ("Greenfield") as their programme for the start-up and commissioning of the Petroteq Oil Sands Plant ("POSP") at the Asphalt Ridge Facility in Utah, USA, was delayed and this work is still progressing. As previously noted, the availability of oil samples for testing at QRF is a critical path item on this programme, and sample testing will be completed within 2-3 weeks of receipt at QRF. The MSAR® manufacturing unit and associated systems are ready to be shipped to the site in Utah, and the c100t MSAR® trial is now planned to take place at POSP during H1 2021, and assuming smooth progress is made, should be completed within 1 week of commissioning the MSAR® Manufacturing Unit and associated systems. The final trial schedule is dependent on Greenfield being able to promptly deliver samples to QRF, shipment of the MSAR® fuel systems, and Quadrise being able to gain safe access to the POSP site in Utah.

 

 

Mike Kirk, Chairman of Quadrise, commented:

We are pleased that positive momentum has been maintained on our projects in Morocco and Utah. In Morocco, our proactive approach to managing risks and timelines has paid dividends throughout 2020 and into 2021, and our client remains very supportive and keen for the remaining trials to progress at pace. In Utah, we front-loaded the preparation for the MMU and associated systems which are ready to ship to site at Greenfield's request, with the confirmatory sample testing being used to refine the additive package for the production trial. The first half of 2021 will be very busy for Quadrise, and we look forward to demonstrating strong progress across all of our active projects, including the recently announced JDA with MSC to enable the planning for the Operational Trial in 2021 and the continued development and testing of our exciting new bio/renewable fuel, bioMSAR™."

 

 

For further information, please contact:

 

Quadrise Fuels International Plc

 

Mike Kirk, Chairman

+44 (0)20 7031 7321

Jason Miles, Chief Executive Officer

ir@quadrisefuels.com

 

 

Nominated Adviser

 

Cenkos Securities plc

 

Ben Jeynes

Katy Birkin

+44 (0)20 7397 8900

 

 

Joint Brokers

 

Peel Hunt LLP

 

Richard Crichton

+44 (0)20 7418 8900

David McKeown

 

 

 

Shore Capital Stockbrokers Limited

 

Toby Gibbs

Fiona Conroy

+44 (0)20 7408 4090

 

 

Public & Investor Relations

 

FTI Consulting

 

Ben Brewerton

+44 (0)20 3727 1000

Ntobeko Chidavaenzi

 

 

Notes to Editors

 

QFI is the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, a low-cost environmentally beneficial alternative to heavy fuel oil for the global power generation, shipping, industrial and refining industries.

 

 

The information communicated within this announcement was deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 prior to the release of this announcement. Upon the publication of this announcement, this inside information is now considered to be in the public domain. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUUWPUPGUQP
Date   Source Headline
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
6th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20218:00 amEQSEdison Investment Research Limited: Quadrise Fuels International (QFI): Cleaner fuel, cleaner planet
26th Nov 20213:30 pmRNSResult of AGM
26th Nov 20217:00 amRNSAGM Statement
1st Nov 20215:00 pmRNSPosting of Annual Report and Notice of AGM
20th Oct 20215:45 pmRNSMorocco Travel Restrictions
5th Oct 20214:41 pmRNSSecond Price Monitoring Extn
5th Oct 20214:35 pmRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSFinal Results, Directorate Change & Notice of AGM
1st Oct 20217:00 amRNSTotal Voting Rights
24th Sep 20217:00 amRNSNotice of Results and Investor Presentation
23rd Sep 20217:00 amRNSUtah Project Update
20th Sep 20214:36 pmRNSPrice Monitoring Extension
3rd Sep 20212:30 pmRNSIssue of Share Options & Director/PDMR Dealing
2nd Sep 20214:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSPublication of bioMSAR Test Results
23rd Aug 20217:00 amRNSGreenfield Commercial Trial Agreement Extension
11th Aug 20217:00 amRNSUpdate on bioMSAR™ Testing
4th Aug 20217:00 amRNSUtah Project Update
30th Jul 20219:30 amRNSBlock Admissions
16th Jul 20214:40 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
16th Jul 20211:15 pmRNSDirectorate Change
28th Jun 20217:00 amRNSUpdate on bioMSAR™ and MSAR® projects
17th May 20214:40 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
4th May 20219:24 amRNSIssue of Equity
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:36 pmRNSPrice Monitoring Extension
16th Apr 20214:40 pmRNSSecond Price Monitoring Extn
16th Apr 20214:35 pmRNSPrice Monitoring Extension
1st Apr 202112:50 pmRNSUpdate re Greenfield Commercial Trial Agreement
29th Mar 20217:00 amRNSInterim Results
25th Mar 20214:40 pmRNSSecond Price Monitoring Extn
25th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSResults of Open Offer
12th Mar 20217:00 amRNSHolding(s) in Company
10th Mar 20217:00 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSResults of Placing and Open Offer Launch
1st Mar 20214:41 pmRNSProposed Placing and Open Offer
25th Feb 20214:41 pmRNSSecond Price Monitoring Extn
25th Feb 20214:35 pmRNSPrice Monitoring Extension
23rd Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSFinal Issue of Convertible Securities
4th Feb 20214:41 pmRNSSecond Price Monitoring Extn
4th Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.